TFXTELEFLEX INC
Surgical & Medical Instruments & Apparatus
- Revenue
- $2.0B
- 17% YoY
- Operating margin
- 5.9%
- 2.6% YoY
- EBITDA
- $296M
- 12% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- 8.5×
- $2.5B net debt
- AI in 10-K
- —
Red flags 1 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear—Cash flow under 80% of net income
- Dilutive SBCClear1% of revenueOver 10% of revenue
- Payouts exceed cash flowFired373% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear34% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $2.8B | $2.8B | $1.7B | $1.7B | $2.0B | 17% |
| Operating income | $628M | $500M | $259M | $104M | $118M | 14% |
| Net income | $485M | $363M | $358M | $70M | −$906M | 1391% |
| Operating cash flow | $652M | $343M | $206M | $302M | $97M | 68% |
| Capex | $72M | $79M | $46M | $90M | $95M | 5.3% |
| Stock-based comp | $23M | $27M | $27M | $26M | $26M | 1.0% |
| Buybacks | — | $0 | $0 | $200M | $300M | 50% |
| Dividends | $64M | $64M | $64M | $64M | $60M | 5.2% |
Deal filings
None.
13D filers
None on file.
Insider trading
No open-market trades in the last 12 months.
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2025 | $7M | $2M | 31 | 123 |
| FY2024 | $9M | $3M | 48 | 135 |
| FY2023 | $9M | $9M | 67 | 123 |
| FY2022 | $8M | $5M | 67 | 112 |
| FY2021 | $9M | $4M | 88 | 142 |